Changes in Roche Board of Directors
OREANDA-NEWS. At its December meeting, the Board of Directors (BoD) of Roche Holding decided on first proposals for approval by the Annual General Meeting (AGM), scheduled for 14 March 2017. Professor Pius Baschera, a member of the BoD since 2007, has decided not to stand for re-election at the AGM in 2017 following 10 years of tenure. The BoD proposes Anita Hauser, Vice-Chairwoman of the Board of Directors of Bucher Industries AG, for election to the BoD at the 2017 AGM.
“As a member of the Board and of the Corporate Governance and Sustainability Committee, Pius Baschera has made significant contributions to Roche’s success,” said Roche Chairman Christoph Franz. “On behalf of the Roche Board of Directors, I would like to extend our sincerest thanks to him.” Christoph Franz added: “I am delighted with our nomination of Anita Hauser for election as a new member of the Board. She is a successful Swiss business leader with extensive experience in a globally operating family company and a strong marketing and sales skills set.”
The following current members of the BoD are recommended for re-election:
Name | Board member since |
---|---|
Dr Christoph Franz (as Chairman) | 2011 |
Andre Hoffmann | 1996 |
Professor Sir John Irving Bell | 2001 |
Julie Brown | 2016 |
Paul Bulcke | 2011 |
Professor Dr Richard P. Lifton | 2015 |
Dr Andreas Oeri | 1996 |
Bernard Poussot | 2015 |
Dr Claudia Suessmuth Dyckerhoff | 2016 |
Dr Severin Schwan | 2013 |
Peter R. Voser | 2011 |
About Roche
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people's lives.
Roche is the world's largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best possible way.
Комментарии